Spots Global Cancer Trial Database for stage iv papillary thyroid cancer
Every month we try and update this database with for stage iv papillary thyroid cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Paclitaxel and Bortezomib in Treating Patients With Metastatic or Unresectable Malignant Solid Tumors | NCT00667641 | Breast Cancer Colorectal Canc... Head and Neck C... Lung Cancer Melanoma (Skin) Ovarian Cancer Pancreatic Canc... Prostate Cancer Unspecified Adu... | bortezomib paclitaxel | 18 Years - | Rutgers, The State University of New Jersey | |
| Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer | NCT00005842 | Cancer | trastuzumab tipifarnib | 18 Years - | National Cancer Institute (NCI) | |
| NGR-TNF in Treating Patients With Advanced Solid Tumors | NCT00098943 | Colorectal Canc... Head and Neck C... Kidney Cancer Unspecified Adu... | CNGRC peptide-T... | 18 Years - | European Organisation for Research and Treatment of Cancer - EORTC | |
| Gefitinib in Treating Patients With Locally Advanced or Metastatic Thyroid Cancer That Did Not Respond to Iodine Therapy | NCT00095836 | Head and Neck C... | Gefitinib | 18 Years - | Massachusetts General Hospital | |
| Bortezomib in Treating Patients With Metastatic Thyroid Cancer That Did Not Respond to Radioactive Iodine Therapy | NCT00104871 | Insular Thyroid... Recurrent Thyro... Stage II Follic... Stage II Papill... Stage IV Follic... Stage IV Papill... | Bortezomib | 18 Years - | National Cancer Institute (NCI) | |
| Boronophenylalanine-Fructose Complex (BPA-F) and/or Sodium Borocaptate (BSH) Followed By Surgery in Treating Patients With Thyroid Cancer, Head and Neck Cancer, or Liver Metastases | NCT00062348 | Colorectal Canc... Head and Neck C... Metastatic Canc... | boronophenylala... sodium borocapt... conventional su... | 18 Years - | European Organisation for Research and Treatment of Cancer - EORTC | |
| Combination Chemotherapy and Tamoxifen in Treating Patients With Solid Tumors | NCT00002608 | Adrenocortical ... Brain and Centr... Head and Neck C... Liver Cancer Malignant Mesot... Pheochromocytom... Sarcoma | cisplatin doxorubicin hyd... tamoxifen citra... conventional su... radiation thera... | - 65 Years | National Cancer Institute (NCI) | |
| Paclitaxel and Bortezomib in Treating Patients With Metastatic or Unresectable Malignant Solid Tumors | NCT00667641 | Breast Cancer Colorectal Canc... Head and Neck C... Lung Cancer Melanoma (Skin) Ovarian Cancer Pancreatic Canc... Prostate Cancer Unspecified Adu... | bortezomib paclitaxel | 18 Years - | Rutgers, The State University of New Jersey | |
| High Dose vs Low Dose I 131 +/- rhTSH for Differentiated Thyroid Cancer | NCT00415233 | Head and Neck C... | recombinant thy... Radiodine ablat... | 16 Years - 80 Years | University College, London | |
| Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer | NCT00005842 | Cancer | trastuzumab tipifarnib | 18 Years - | National Cancer Institute (NCI) | |
| Azacitidine to Restore Thyroid Function in Patients With Persistent or Metastatic Thyroid Cancer | NCT00004062 | Head and Neck C... | azacitidine liothyronine so... iodine I 131 | - | National Cancer Institute (NCI) | |
| Suberoylanilide Hydroxamic Acid in Treating Patients With Metastatic and/or Locally Advanced or Locally Recurrent Thyroid Cancer | NCT00134043 | Insular Thyroid... Recurrent Thyro... Stage II Follic... Stage II Papill... Stage IV Follic... Stage IV Papill... Thyroid Gland M... | vorinostat | 18 Years - | National Cancer Institute (NCI) | |
| Vaccine Therapy Plus Biological Therapy in Treating Adults With Metastatic Solid Tumors | NCT00019331 | Colorectal Canc... Endometrial Can... Head and Neck C... Liver Cancer Lung Cancer Melanoma (Skin) Pancreatic Canc... Testicular Germ... Unspecified Adu... | aldesleukin ras peptide can... sargramostim DetoxPC | 18 Years - | National Cancer Institute (NCI) | |
| Sorafenib Tosylate in Treating Patients With Locally Advanced, Metastatic, or Locally Recurrent Thyroid Cancer | NCT00095693 | Anaplastic Thyr... Insular Thyroid... Recurrent Thyro... Stage III Folli... Stage III Papil... Stage IV Follic... Stage IV Papill... | sorafenib tosyl... laboratory biom... pharmacological... fludeoxyglucose... positron emissi... dynamic contras... | 18 Years - | National Cancer Institute (NCI) | |
| Everolimus in Treating Patients With Progressive or Recurrent, Unresectable, or Metastatic Thyroid Cancer | NCT01118065 | Head and Neck C... | everolimus | 18 Years - | National Cancer Institute (NCI) | |
| Bortezomib in Treating Patients With Metastatic Thyroid Cancer That Did Not Respond to Radioactive Iodine Therapy | NCT00104871 | Insular Thyroid... Recurrent Thyro... Stage II Follic... Stage II Papill... Stage IV Follic... Stage IV Papill... | Bortezomib | 18 Years - | National Cancer Institute (NCI) | |
| Thalidomide in Treating Patients With Thyroid Cancer | NCT00026533 | Head and Neck C... | thalidomide | 18 Years - 120 Years | University of Kentucky | |
| NGR-TNF in Treating Patients With Advanced Solid Tumors | NCT00098943 | Colorectal Canc... Head and Neck C... Kidney Cancer Unspecified Adu... | CNGRC peptide-T... | 18 Years - | European Organisation for Research and Treatment of Cancer - EORTC | |
| Tanespimycin in Treating Patients With Inoperable Locoregionally Advanced or Metastatic Thyroid Cancer | NCT00118248 | Recurrent Thyro... Stage IV Follic... Stage IV Papill... Thyroid Gland M... | tanespimycin | 18 Years - | National Cancer Institute (NCI) | |
| Gefitinib in Treating Patients With Locally Advanced or Metastatic Thyroid Cancer That Did Not Respond to Iodine Therapy | NCT00095836 | Head and Neck C... | Gefitinib | 18 Years - | Massachusetts General Hospital | |
| Tanespimycin in Treating Patients With Inoperable Locoregionally Advanced or Metastatic Thyroid Cancer | NCT00118248 | Recurrent Thyro... Stage IV Follic... Stage IV Papill... Thyroid Gland M... | tanespimycin | 18 Years - | National Cancer Institute (NCI) | |
| Sorafenib Tosylate in Treating Patients With Locally Advanced, Metastatic, or Locally Recurrent Thyroid Cancer | NCT00095693 | Anaplastic Thyr... Insular Thyroid... Recurrent Thyro... Stage III Folli... Stage III Papil... Stage IV Follic... Stage IV Papill... | sorafenib tosyl... laboratory biom... pharmacological... fludeoxyglucose... positron emissi... dynamic contras... | 18 Years - | National Cancer Institute (NCI) | |
| Suberoylanilide Hydroxamic Acid in Treating Patients With Metastatic and/or Locally Advanced or Locally Recurrent Thyroid Cancer | NCT00134043 | Insular Thyroid... Recurrent Thyro... Stage II Follic... Stage II Papill... Stage IV Follic... Stage IV Papill... Thyroid Gland M... | vorinostat | 18 Years - | National Cancer Institute (NCI) | |
| Celecoxib in Treating Patients With Progressive Metastatic Differentiated Thyroid Cancer | NCT00061906 | Head and Neck C... | celecoxib | 18 Years - | Ohio State University Comprehensive Cancer Center | |
| Everolimus in Treating Patients With Locally Advanced or Metastatic Thyroid Cancer | NCT01164176 | Head and Neck C... | everolimus laboratory biom... | 18 Years - | Yonsei University | |
| High Dose vs Low Dose I 131 +/- rhTSH for Differentiated Thyroid Cancer | NCT00415233 | Head and Neck C... | recombinant thy... Radiodine ablat... | 16 Years - 80 Years | University College, London |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
